SGHT
Sight Sciences IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$187.94M
P/E Ratio
—
EPS
$-0.74
Beta
2.49
52W High
$9.24
52W Low
$2.24
50-Day MA
$4.84
200-Day MA
$5.10
Dividend Yield
—
Profit Margin
-49.70%
Forward P/E
—
PEG Ratio
—
About Sight Sciences Inc
Sight Sciences Inc. (SGHT) is a pioneering medical technology company focused on transforming the management of eye diseases through innovative surgical and non-surgical solutions, particularly targeting glaucoma care. With a robust portfolio of cutting-edge products and a strong intellectual property foundation, the company is strategically positioned to capitalize on the increasing demand for minimally invasive therapies in the ophthalmology sector. As Sight Sciences expands its distribution network and continues to drive advancements in eye care, it presents a compelling investment opportunity for institutional investors looking to engage with the dynamic healthcare market.
Fundamentals
| Revenue (TTM) | $77.36M |
| Gross Profit (TTM) | $66.67M |
| EBITDA | $-33.81M |
| Operating Margin | -18.00% |
| Return on Equity | -50.70% |
| Return on Assets | -16.60% |
| Revenue/Share (TTM) | $1.48 |
| Book Value | $1.20 |
| Price-to-Book | 2.97 |
| Price-to-Sales (TTM) | 2.43 |
| EV/Revenue | 1.796 |
| EV/EBITDA | -4.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.90% |
| Shares Outstanding | $54.01M |
| Float | $31.66M |
| % Insiders | 21.16% |
| % Institutions | 53.20% |
Analyst Ratings
Consensus ($8.50 target)
1
Strong Buy3
Buy2
HoldData last updated: 4/9/2026